Genetic stability of rDNA production systems, a case report

Area of Science:

• Biotechnology and genetic engineering
• Pharmaceutical manufacturing
• Molecular biology

Background:

• Recombinant DNA (rDNA) proteins for human therapeutics rely on robust biological production systems.
• Master cell banks are genetically and biochemically characterized for consistency.
• Maintaining genetic stability through extensive cell propagation is critical for product quality.

Purpose of the Study:

• To investigate the genetic stability of biological production systems, specifically plasmids in E. coli or yeast, over numerous cell generations.
• To determine the impact of genetic alterations on the quality of rDNA therapeutic proteins.
• To establish criteria for evaluating fermentation runs based on genetic stability.

Main Methods:

• Analysis of plasmid DNA structure (size, restriction analysis) from cells at different culture stages.
• Sequence determination of critical plasmid DNA regions.
• Monitoring plasmid integrity throughout large-scale cell culture (tens of thousands of litres).

Main Results:

• Structural alterations in plasmids were observed during cell propagation.
• Some plasmid alterations occurred with high frequency or concentration.
• These genetic changes can impact the consistency and quality of the final therapeutic product.

Conclusions:

• Genetic instability, particularly plasmid alteration, is a significant factor in rDNA protein production.
• Consistent maintenance of genetic characteristics is essential for ensuring therapeutic product quality.
• Genetic analysis provides a basis for establishing acceptance criteria for fermentation runs.